Seattle Genetics, a company that conducts cancer research, has recently been the topic of many discussions due to their new development of cancer fighting agents. The company has been developing these new antibiotic treatments for the last several years and have recently been approved for funding that can take their research to a new level. Dr. Clay Siegall, the Chief Executive Officer and President of Seattle Genetics, has recently given an interview regarding the new changes at his company. He has stated that he is extremely excited about the changes that Seattle Genetics is making in the cancer research industry and hopes that this new advancement will be instrumental in the healing of millions of people who suffer from cancer.
The new development that Seattle Genetics has been working on for the last several years is comprised of a medication that actively fights cancer antibodies in a patients body. If a person’s body is infected with cancer, cancer antibodies begin to grow at a rapid pace in the body. These antibodies create cells that actually kill the healthy cells and grow at a swift rate so that white blood cells can not kill them. By developing this new antibody fighting drug, Seattle Genetics has effectively changed the cancer industry. Now, there is a drug available that can specifically target the cancer cells and not the healthy cells in a patients body.
With most cancer fighting drugs, like chemotherapy for instance, the medicine works by targeting the cancer cells and the healthy cells in a patient’s body. The problem with these drugs have been that they generally cause the patient’s body to attack itself while it is attacking the cancer cells. This is the reason that most cancer patients become so ill and begin to lose their hair and the functionality in their bodies. The medicine has been formulated in such a way that it cannot distinguish between healthy and cancerous cells. This new development by Dr. Clay Siegall and his team at Seattle Genetics is a true innovation in the cancer research industry and can dramatically improve the lives of cancer patients around the world.
— Seattle Genetics (@SeattleGenetics) May 11, 2016